Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation.
Tchervenkov
J
J
Department of Medicine and Surgery, McGill University, Montreal, Canada.
Flemming
C
C
Guttmann
R D
RD
des Gachons
G
G
D000208:Acute Disease; D000818:Animals; D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011817:Rabbits
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; C512542:thymoglobulin